


Ask a doctor about a prescription for VARDENAFIL CINFA 20 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Vardenafilo Cinfa 20 mg film-coated tablets EFG
vardenafil hydrochloride trihydrate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Vardenafilo Cinfa contains vardenafil, which belongs to a group of medicines called phosphodiesterase 5 inhibitors, used to treat erectile dysfunction in adult men, a condition that consists of difficulty in achieving or maintaining an erection.
At least one in ten men has, at some point, problems getting or maintaining an erection. This can be due to physical or psychological causes, or a combination of both.
Regardless of the cause, muscle and blood vessel disorders cause insufficient blood to flow to the penis to achieve and maintain an erection.
Vardenafil will only work when you are sexually stimulated. This medicine reduces the action of a natural substance in the body that prevents erection. Vardenafil allows you to achieve an erection with sufficient duration to maintain a satisfactory sexual relationship.
Do not take Vardenafilo Cinfa
Warnings and precautions
Consult your doctor or pharmacist before starting to take Vardenafilo Cinfa.
Be careful with Vardenafilo Cinfa
Children and adolescents
Vardenafil should not be used in children or adolescents under 18 years of age.
Other medicines and Vardenafilo Cinfa
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
Some medicines may cause problems, especially the following:
Do not use vardenafil film-coated tablets in combination with any other medicine for the treatment of erectile dysfunction, including vardenafil orodispersible tablets.
Taking Vardenafilo Cinfa with food, drinks, and alcohol
Pregnancy and breastfeeding
Vardenafil should not be used in women.
Driving and using machines
In some people, vardenafil can cause dizziness or affect vision. Do not drive or use tools or machines if you feel dizzy or have vision problems after taking vardenafil.
Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is 10 mg.
Take a vardenafil tablet 25 to 60 minutes, approximately, before sexual activity. With sexual stimulation, you will be able to achieve an erection from 25 minutes to 4 or 5 hours after taking vardenafil.
Swallow the tablet with a glass of water.
Do not take Vardenafilo Cinfa film-coated tabletswith any other formulation of vardenafil.
Do not take vardenafilmore than once a day.
If you think the action of vardenafil is too strong or too weak, inform your doctor. He or she may suggest changing to another formulation of vardenafil with a different dose based on the effect it has on you.
If you take more Vardenafilo Cinfa than you should
Taking too many vardenafil tablets can cause more side effects or produce intense back pain. In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Most of these side effects are mild or moderate.
Some patients have experienced sudden vision loss or partial vision loss, distorted, attenuated, or blurred vision, temporarily or permanently, in one or both eyes. Stop taking vardenafil and contact your doctor immediately.
There have also been reports of sudden hearing loss.
There have been reports of sudden death, rapid or altered heartbeats, heart attacks, chest pain, and circulation problems (including temporary reduction of blood flow to parts of the brain and cerebral hemorrhage), in men taking vardenafil. Most men who experienced these side effects had pre-existing heart problems before taking this medicine. It is not possible to determine if these events were directly related to vardenafil.
The possibility of presenting a side effect is described through the following categories:
Very common side effects:
may affect more than 1 in 10 people
Common side effects:
may affect up to 1 in 10 people
Uncommon side effects:
may affect up to 1 in 100 people
Rare side effects:
may affect up to 1 in 1,000 people
Very rare or unknown frequency side effects:
may affect up to 1 in 10,000 people or the frequency cannot be estimated from the available data
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Healthcare Products Agency's Pharmacovigilance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month shown.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Return the containers and any unused medicines to the pharmacy. If you have any doubts, ask your pharmacist how to dispose of containers and unused medicines. This will help protect the environment.
Composition of Vardenafilo Cinfa
In the tablet core: crospovidone, magnesium stearate, microcrystalline cellulose, anhydrous colloidal silica.
In the film coating: OPADRY Y-1-7000 (macrogol 400, hypromellose, titanium dioxide (E171)), yellow iron oxide (E172), and red iron oxide (E172).
Appearance of the product and pack contents
Vardenafilo Cinfa 20 mg are orange, film-coated, biconvex, cylindrical tablets, engraved with the logo VR2.
They are presented in aluminum/aluminum blisters. Each pack contains 2, 4, or 8 tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra) Spain
Date of last revision of this leaflet:February 2025
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/.
You can access detailed and updated information about this medicine by scanning the QR code included in the leaflet and packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/81751/P_81751.html
QR code to: https://cima.aemps.es/cima/dochtml/p/81751/P_81751.html
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for VARDENAFIL CINFA 20 mg FILM-COATED TABLETS – subject to medical assessment and local rules.